Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
LXRX · NASDAQ · Pharmaceutical Preparations
$1.53−0.14 (−8.38%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Lexicon Pharmaceuticals (LXRX) · oqro.io/stocks/LXRX · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
Insider trade · Traded Nov 6, 2026 · Filed Nov 9, 2026
CEO purchased ~$50K of LXRX shares in the open marketSourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Sessa Capital IM, L.P. disclosed an increased position in LXRX for Q2 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Sessa Capital IM, L.P. disclosed an increased position in LXRX for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 14, 2026
Siren, L.L.C. disclosed an increased position in LXRX for Q1 2026SourceInsider trade · Traded Feb 25, 2026 · Filed Feb 27, 2026
Director purchased ~$3K of LXRX shares in the open marketSourceInsider trade · Traded Feb 23, 2026 · Filed Feb 25, 2026
Director purchased ~$147K of LXRX shares in the open marketSourceInsider trade · Traded Feb 20, 2026 · Filed Feb 23, 2026
Director purchased ~$148K of LXRX shares in the open marketSourceInsider trade · Traded Feb 19, 2026 · Filed Feb 23, 2026
Director purchased ~$72K of LXRX shares in the open marketSourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Orbimed Advisors LLC no longer reported LXRX for Q4 2024SourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
Orbimed Advisors LLC disclosed an increased position in LXRX for Q3 2024SourceInsider trade · Traded Feb 18, 2026 · Filed Feb 18, 2026
Director purchased ~$176K of LXRX shares in the open marketSourceInsider trade · Traded Feb 17, 2026 · Filed Feb 18, 2026
Director purchased ~$101K of LXRX shares in the open marketSourceInsider trade · Traded Feb 13, 2026 · Filed Feb 18, 2026
Director purchased ~$76K of LXRX shares in the open marketSourceInsider trade · Traded Feb 2, 2026 · Filed Feb 4, 2026
Director purchased ~$2M of LXRX shares in the open marketSource